2025
ICD-10-CM
Diagnosis
Code

D75.81 Myelofibrosis

  • Billable
  • 2016–2025

D75.81 is a billable/specific diagnosis code from the 2025 ICD-10-CM used to classify the following condition: Myelofibrosis.

Inclusion term

  • Myelofibrosis NOS

  • Secondary myelofibrosis NOS

Code first

  • The underlying disorder, such as:

    • Malignant neoplasm of breast (C50.-)

Use additional code

  • Code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)

Type 1 excludes

  • Acute myelofibrosis (C94.4-)

  • Idiopathic myelofibrosis (D47.1)

  • Leukoerythroblastic anemia (D61.82)

  • Myelofibrosis with myeloid metaplasia (D47.4)

  • Myelophthisic anemia (D61.82)

  • Myelophthisis (D61.82)

  • Primary myelofibrosis (D47.1)

Versions

  1. 2025

    No changes

  2. 2024

    No changes

  3. 2023

    No changes

  4. 2022

    No changes

  5. 2021

    No changes

  6. 2020

    No changes

  7. 2019

    No changes

  8. 2018

    No changes

  9. 2017

    Code changed

    • Use additional code

        • code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
        • code for adverse effect, if applicable, to identify drug (T45.1X5)
        • code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)

  10. 2016

    New code